Efficacy and Safety of Open-Label Maintenance Therapy with Subcutaneous Risankizumab in Patients with Moderateto-Severe Crohn's Disease
Feagan, Brian G., Panes, Julian, Ferrante, Marc, Kaser, Arthur, D'Haens, Geert R., Sandborn, William J., Louis, Edouard, Neurath, Markus, Franchimont, Denis, Dewit, Olivier, Seidler, Ursula, Kim, KyunVolume:
152
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(17)34361-5
Date:
April, 2017
File:
PDF, 768 KB
english, 2017